ValGenesis

ValGenesis is a leading startup in the life sciences industry, offering paperless validation software for biotech, pharma, medical device, and other related sectors. Founded in 2005 and headquartered in the United States, the company has garnered significant attention from investors, with its most recent $24.00M Private Equity Round investment on 04 May 2021 led by Morgan Stanley Expansion Capital.

Their slogan "The industry standard paperless validation software for biotech, pharma, medical device and other life sciences" signifies their commitment to revolutionizing validation and manufacturing processes in the healthcare industry. ValGenesis delivers integrated and smart solutions to support the digital transformation of life sciences, providing a portfolio that covers the entire product lifecycle.

With a focus on Medical Devices and Pharmaceutical industries, ValGenesis offers digital and technical solutions that bring substantial value to each step of the validation and manufacturing processes, as well as related activities. Their innovative approach and recent investment from Morgan Stanley Expansion Capital position them for further growth and success in the evolving life sciences sector.